ArticleCureus2026
Edoxaban Resolved a Left Atrial Thrombus Intruding From the Right Lower Pulmonary Vein and Increased Cerebral Blood Flow: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary vein thrombosis (PVT) is thought to be rare; however, since 2012, the author has used 64- or 80-slice multidetector computed tomography (64- or 80-MDCT) to describe several cases of PVT. Some reports have involved the use of transesophageal echocardiography (TEE) to characterize PVT. Notably, the mechanism of how edoxaban affects thrombi in the pulmonary vein and left atrium and cerebral blood flow is poorly understood. An 85-year-old female with hypertension had a thrombus in her right lower pulmonary vein (RLPV) that intruded into the left atrium and exhibited snake-like characteristics when examined using TEE. The left atrium portion of the thrombus could be accurately imaged via TEE but not via 80-MDCT because it was thin and moved periodically. After six months of edoxaban treatment, the thrombus in the left atrium disappeared, as demonstrated by TEE, and cerebral blood flow increased, as measured by brain perfusion single-photon emission computed tomography (SPECT). Blood flow and a moving thrombus in the heart can be evaluated using TEE. Assessments via 80-MDCT alone may underestimate the incidence of a thrombus. Edoxaban ameliorated cerebral blood flow after six months of treatment, as measured via brain perfusion SPECT. Of note, treatment might reduce morbidity and prevent complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.